GMTX - Gemini Therapeutics, Inc. /de - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - GMTX (1816736)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
35 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-03-05
IRONBitterman KevinDirS - Sale$73.50-26,157926,829-3%-$1,922,540
2024-01-23
IRONBitterman KevinDirS - Sale$67.65-102,500249,326-29%-$6,934,125
2024-01-23
IRONAtlas Venture Fund X, L.P.10%S - Sale$67.65-150,0001,600,512-9%-$10,147,500
2024-01-10
IRONBitterman KevinDirS - Sale$64.00-20,0001,055,486-2%-$1,280,000
2024-01-10
IRONAtlas Venture Fund X, L.P.10%S - Sale$64.00-50,0002,235,846-2%-$3,200,000
D
2023-12-18
IRONOrbimed Advisors LLCDirS - Sale+OE$59.24-1,7241,702,2370%-$102,130
D
2023-12-18
IRONAshiya MonaDirS - Sale+OE$59.24-1,7241,702,2370%-$102,130
2023-12-14
IRONAshiya MonaDirS - Sale$56.75-433,200224,405-66%-$24,584,100
2023-12-14
IRONOrbimed Advisors LLCDirS - Sale$56.75-433,200224,405-66%-$24,584,100
M
2023-12-12
IRONBitterman KevinDirS - Sale$61.45-76,0641,075,486-7%-$4,673,759
M
2023-12-12
IRONAtlas Venture Fund X, L.P.10%S - Sale$61.45-190,1632,285,846-8%-$11,684,586
M
2023-12-12
IRONOrbimed Advisors LLCDirS - Sale$58.88-134,200727,807-16%-$7,902,266
M
2023-12-12
IRONAshiya MonaDirS - Sale$58.88-134,200727,807-16%-$7,902,266
D
2023-12-12
IRONWhite William RichardDirS - Sale+OE$63.21-33,5110-100%-$2,118,239
D
2023-12-12
IRONBryce JoanneCFOS - Sale+OE$65.22-2,5002,500-50%-$163,062
D
2023-12-05
IRONBryce JoanneCFOS - Sale+OE$56.00-2,5412,500-50%-$142,299
D
2023-11-22
IRONKhara RahulGCS - Sale+OE$51.73-10,0000-100%-$517,333
D
2023-11-14
IRONKhara RahulGCS - Sale+OE$50.61-4,9000-100%-$248,012
D
2023-11-03
IRONKhara RahulGCS - Sale+OE$50.00-1000-100%-$5,000
M
2023-09-14
IRONAtlas Venture Fund X, L.P.10%S - Sale$53.13-357,4491,593,785-18%-$18,991,727
D
2023-09-01
IRONBryce JoanneCFOS - Sale+OE$52.99-1,0001,260-44%-$52,990
2023-08-15
IRONBitterman KevinDirS - Sale$52.40-72,9311,151,550-6%-$3,821,584
M
2023-08-14
IRONAtlas Venture Fund X, L.P.10%S - Sale$52.49-359,0002,833,458-11%-$18,845,200
2023-08-15
IRONSavage William JacobChief Medical OfficerS - Sale$52.95-7,6720-100%-$406,235
2023-08-09
IRONSavage William JacobChief Medical OfficerS - Sale$49.83-8,2697,672-52%-$412,064
D
2023-08-01
IRONBryce JoanneCFOS - Sale+OE$49.91-4,5211,260-78%-$225,633
M
2023-06-28
IRONMacdonald Brian RichardChief Innovation OfficerS - Sale$47.02-15,12415,564-49%-$711,140
D
2023-06-28
IRONBryce JoanneCFOS - Sale+OE$49.95-10,0721,260-89%-$503,114
2023-06-28
IRONSavage William JacobChief Medical OfficerS - Sale$49.98-4,38415,941-22%-$219,114
2023-06-28
IRONNovo Holdings A/s10%S - Sale$46.10-1,250,0001,090,772-53%-$57,625,000
2023-02-15
IRONAshiya MonaDir, 10%P - Purchase$23.00+108,696299,205+57%+$2,500,008
2023-02-15
IRONOrbimed Advisors LLCDir, 10%P - Purchase$23.00+108,696299,205+57%+$2,500,008
2023-02-15
IRONAi Dmi LLC10%P - Purchase$23.00+434,7833,141,759+16%+$10,000,009
2022-10-26
GMTXLeonard Braden Michael10%S - Sale$2.09-22,5005,247,5000%-$47,025
M
2022-04-12
GMTXLeonard Braden Michael10%P - Purchase$1.40+955,0005,270,000+22%+$1,337,929

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top